Potent JAK inhibitor ruxolitinib down-regulates ubiquitin specific peptidase genes in chronic myeloid leukemia cells.


GÖKER B. , ÇALIŞKAN KURT C., SAYDAM G. , GÜNDÜZ C. , BİRAY AVCI Ç.

4th Aegean Hematology Oncology Symposium, 21 - 24 Eylül 2017